NovoCure (NVCR) Stock Highlights

30.8 | +1.32%

2024-12-21 03:38:36

NovoCure Ltd serves in the healthcare sector of the United States. Its business involves commercial-stage oncology operations involving therapies to cure critical tumors. Its pipeline consists of Ovarian Cancer, Pancreatic Cancer, Non-Small Cell Lung Cancer, and Brain Metastasis. NovoCure derives its major revenues in the United States.

Statistics

Range Today

30.33 31.52

Volume Today 1.82M

Range 1 Year

11.7 34.13

Volume 1 Year 337.1M

Range 3 Year

10.87 120.03

Volume 3 Year 830.13M

Range 10 Year

5.95 232.76

Volume 10 Year 2.02B

Highlights

Market Capitalization 1.89B (small)

Floating Shares 98.52M

Current Price 30.8

Price To Earnings -12.88

Price To Revenue 2.77

Price To Book 5.23

Earnings Per Share -1.37

Payout Ratio 0%

Performance

Latest +1.32%

1 Month +89.42%

3 Months +73.23%

6 Months +60.42%

1 Year +128.15%

3 Years -63.25%

5 Years -63.91%

10 Years +40%

Benchmarks

Market Capitalization

23 / 44

Gross Profits

19 / 40

Total Revenue

21 / 43

Total Rank

20 / 44

Free Cashflow

14 / 44

Performance 5 years

35 / 44

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.